NEW YORK (GenomeWeb) – BioMérieux today reported that its first quarter revenues rose 16 percent year over year, driven in large part by growth in clinical applications including FilmArray molecular diagnostic products.

The firm also said today that its FilmArray Respiratory Panel 2 Plus has received the CE mark, and that it has submitted a 510(k) application to the US Food and Drug Administration for the panel.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.